secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001079973-24-001179
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q2 2024 net loss of $298K; rev $2.387M (+5% YoY); SpinDx beta in 2024
-----------------------------------------------------------------------------

- Net loss $(298K) ($0.12/diluted) vs net income $55K ($0.02) in Q2 2023.
- Revenue increased 5% to $2.387M; gross margin fell to 41.6% from 45.7%.
- R&D spending rose 67% to $662K, primarily for SpinDx saliva THC detection.
- Cash at $505K; post-quarter closed $750K credit line + $798K private placement.
- SpinDx beta testing planned H2 2024; commercial launch targeted for 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324001179/0001079973-24-001179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324001179/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-001179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer